None listed
Conditions
Interventions
Biological/Vaccine, Stem Cell : Percutaneous coronary intervention will be performed on patients diagnosed with acute myocardial infarction.
As to retrieve autologous peripheral blood stem cells, Darb
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1st Inclusion Criteria] 1) Acute(within 4 weeks) Myocardial Infartion [2nd Inclusion Criteria] 2) Patients who received successful percutaneous coronary intervention (the criterion for successful angioplasty was defined as TMI III blood flow in the target coronary artery and residual lesion stenosis < 30%) using a DES or DCB for the culprit lesion. (However, DCB are used only when restenosis occurs in lesions target lesion, resulting in myocardial infarction.)
Exclusion criteria
Exclusion criteria: 1) Ongoing end-stage heart failure or symptoms of heart failure (Killip class II or higher or left ventricular ejection rate 2.0mg/dL) 8) Pregnant or lactating patients 9) Patients participating in clinical studies other than the Registry study. However, as long as the validity is not affected, duplicate registration is possible only with the consent of both practitioners.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Myocardiacl SPECT, Left ventricular ejection fraction | — |
Secondary
| Measure | Time frame |
|---|---|
| Regional wall motion score index measured by echocardiography; MACE: death, revascularization of target lesions, readmission;Change in BNP;6-minute walking ability test results | — |
Countries
Korea, Republic of
Contacts
Public ContactYejin lim
Seoul National University Hospital
Outcome results
None listed